Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Jain Global LLC Boosts Stake in Pfizer Inc. $PFE
Focus Partners Wealth Acquires 551,274 Shares of Pfizer Inc. $PFE
CT cannot afford to delay the Southeast Resiliency Project
Pfizer Inc. $PFE Shares Bought by Gotham Asset Management LLC - Markets Daily
Does Apellis Pharmaceuticals' (APLS) New Board Member Reveal a Deeper R&D Commercialization Strategy Shift? - Simply Wall St News
First Western Trust Bank Has $569,000 Position in Pfizer Inc. $PFE - Markets Daily
Gotham Asset Management LLC Grows Position in Pfizer Inc. $PFE
Destination Wealth Management Has $21.92 Million Position in Pfizer Inc. $PFE - Markets Daily
Ameriprise Financial Inc. Increases Holdings in Pfizer Inc. $PFE
Pfizer Inc. $PFE Stake Reduced by First Western Trust Bank - Stock Observer
Is Pfizer Inc. (PFE) A Good Stock To Buy Now?
Empiric azithromycin alters the upper respiratory microbiome and resistome without anti-inflammatory benefit in COVID-19
Is Pfizer Inc. (PFE) One of Goldman Sachs Top Healthcare Stocks?
Pfizer Pipeline Updates Test Valuation Gap As New Trials Begin
Pfizer Inc. $PFE Shares Sold by CSM Advisors LLC
Community Bank N.A. Has $1.60 Million Holdings in Pfizer Inc. $PFE - Stock Observer
Capitolis Liquid Global Markets LLC Purchases 1,351,000 Shares of Pfizer Inc. $PFE - Daily Political
Pfizer Inc. $PFE Shares Acquired by California Public Employees Retirement System - Daily Political
Pfizer (PFE) and Iron Mountain (IRM) lead the Bull Strangle watch list for this week
Goldman Sachs Healthcare Stocks: Top 10 Stock Picks
China Obesity Approval Puts Pfizer's GLP 1 Bet In Sharper Focus
Top Pharmaceutical Stocks To Watch Today - March 14th - Stock Observer
Ossiam Sells 4,709,790 Shares of Pfizer Inc. $PFE
Pfizer Inc. $PFE Shares Sold by Marathon Capital Management
Integral Health Asset Management LLC Trims Holdings in Pfizer Inc. $PFE - Stock Observer
Fairfax Financial Holdings Ltd. Can Buys 240,000 Shares of Pfizer Inc. $PFE - Stock Observer
Comerica Bank Sells 48,571 Shares of Pfizer Inc. $PFE - Stock Observer
Symbol: ZPFE Security name: Pfizer (PFE) BMO CDR (CAD Hedge
Eliquis Outperforms Xarelto in Safety for Treating Deep Blood Clots, ETPharma
Nektar Therapeutics (NASDAQ:NKTR) Q4 2025 Earnings Call Transcript
AI in Life Sciences Market, 2026-2040 Industry Trends and Global Forecasts - IBM, IQVIA and Oracle Lead Data Platforms While Roche, Pfizer and AI Startups Accelerate Drug Discovery Innovation
SeaCrest Wealth Management LLC Has $1.66 Million Stake in Pfizer Inc. $PFE - Daily Political
Martingale Asset Management L P Has $12.88 Million Stock Holdings in Pfizer Inc. $PFE - Daily Political
PENBRAYA (Pfizer) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F | Valuespectrum.com
Building a gene editing lexicon: a model for rare and inherited disorders
Pfizer (NYSE:PFE) Shares Down 1.7% - Here's Why
Rep. Gilbert Ray Cisneros, Jr. Buys Shares of Pfizer Inc. (NYSE:PFE) - Daily Political
BridgeBio Pharma CEO Teases Pipeline Launches, Attruby Momentum, and Pfizer Tafamidis Trial Update - Daily Political
Dividend-paying pharma stock looks poised for a comeback, charts show
Merck's WELIREG Kidney Cancer Trials Deepen Oncology Growth Story
Promising Pharmaceutical Stocks To Watch Now - March 12th - Stock Observer
Radioligand Therapies Market Set for Significant Growth by 2034, Driven by Rising Cancer Burden and Targeted Radiopharmaceutical Innovation | DelveInsight
How Investors Are Reacting To Pfizer (PFE) Phase 2 Win For Tilrekimig In Atopic Dermatitis
Pfizer Inc. $PFE Shares Sold by SevenBridge Financial Group LLC - Markets Daily
The Best Covered Call Strategy to Trade High-Yielding Pfizer Stock and Earn Extra Income
Mackenzie Financial Corp Raises Holdings in Pfizer Inc. $PFE
How Tilrekimig's Trispecific Eczema Data At Pfizer (PFE) Has Changed Its Investment Story
Pfizer's Weight Management Drug Wins China Approval
Franklin Resources Inc. Raises Stock Holdings in Pfizer Inc. $PFE - Daily Political
Pfizer, Teva lose bid to disqualify ex-prosecutor in generic drug price‑fixing case
ctDNA and tumor-based biomarkers of giredestrant response in acelERA breast cancer
Seroprevalence of anti-AAV antibodies in a healthy adult Spanish population: findings from the SAAVIA study
651,996 Shares in Pfizer Inc. $PFE Bought by Kepler Cheuvreux Suisse SA
MNCs, Indian drugmakers diverge to mutual gain: How win-win is it? - Rediff.com
Richard Bernstein Advisors LLC Sells 65,636 Shares of Pfizer Inc. $PFE - Daily Political
Pfizer Tariff Exemptions And US$70b Pledge Reshape Valuation Debate
BioNTech Founders to Leave Company by 2026 for New mRNA Venture, ETPharma
B cell imprinting in children impairs antibodies to the haemagglutinin stalk
Does Olema Pharmaceuticals (OLMA) Still Stand Apart After Roche's Breast Cancer Trial Setback?
Pfizer (NYSE:PFE) Trading 1.2% Higher - Time to Buy?
Pfizer (NYSE:PFE) Trading 1.2% Higher - What's Next? - Daily Political
Pfizer Inc. $PFE Shares Bought by Causeway Capital Management LLC
Neumega (Pfizer, (Wyeth Pharmaceuticals)) Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F
Natixis Advisors LLC Has $44.06 Million Stock Holdings in Pfizer Inc. $PFE - Markets Daily
Comirnaty (Pfizer, BioNTech: Tozinameran) Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F
Health experts discuss new biosimilar treatments for patients in Việt Nam
Banque Cantonale Vaudoise Sells 92,252 Shares of Pfizer Inc. $PFE
Legal & General Group Plc Purchases 3,296,415 Shares of Pfizer Inc. $PFE - Stock Observer
Van ECK Associates Corp Sells 4,744,499 Shares of Pfizer Inc. $PFE - Daily Political
Natixis Advisors LLC Sells 522,523 Shares of Pfizer Inc. $PFE - Stock Observer
GIPR antagonists reported in Pfizer patent | BioWorld
Artifacts worth millions sold illegally in Nanjing Museum scandal
Diagnostic uncertainty of clinical T2 disease and its impact on treatment stratification in upper tract urothelial carcinoma: a multicenter retrospective study
Pfizer (PFE) Valuation Check After New Tilrekimig Phase 2 Success And Pipeline Progress
Neuroendocrine Carcinoma Market Poised for Significant Growth During the Forecast Period (2026-2036) Driven by Rising Incidence and Advancements in Targeted Therapies | DelveInsight
Factbox-Global drugmakers rush to boost US presence as tariff threat looms
Trumenba (Pfizer) Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F
Abrysvo or Arexvy Market Research Report 2026: Epidemiology, Pipeline Analysis, Leading Companies, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F
Pfizer's Tilrekimig Successfully Reduces Eczema Symptoms in Mid-Stage Trial, ETPharma
Prevnar Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F
Swiss National Bank Trims Stake in Pfizer Inc. $PFE
Schroder Investment Management Group Sells 203,688 Shares of Pfizer Inc. $PFE - Markets Daily
562,908 Shares in Pfizer Inc. $PFE Bought by WINTON GROUP Ltd
Pfizer: Tilrekimig Antibody Phase 2 Study Meets Primary Goal In Moderate To Severe Atopic Dermatitis
Pfizer's eczema drug meets main goal in mid-stage trial, plans late-stage study
LGT Group Foundation Buys 423,419 Shares of Pfizer Inc. $PFE
Roche Stock Plummets as Giredestrant Fails Breast Cancer Trial, ETPharma
Pfizer's Phase 2 Study of Trispecific Antibody Positive in Moderate to Severe Atopic Dermatitis
Roche shares dip as oral breast cancer drug fails trial
PFIZER News
Fed Policy at Crossroads: Geopolitical Shocks and Inflationary Pressures
Wall Street Strategists Maintain Bullish Stance on US Equities Amidst Geopolitical Risks
Crypto price prediction: XRP up or down, ETH price target, will BTC surge again?
Commodity trading in Dubai, UAE: real time gold prices, XAU/USD prediction for 2026
Top growth stocks to buy in 2026: Rivian (RIVN) stock, SanDisk (SNDK) stock, Robinhood (HOOD)
Will Nvidia (NVDA) stock hit $300: What is the NVDA price prediction for 2030?
Latest news
Show moreUkraine Peace Talks Nearing Stalemate Amid Shifting US Focus to Iran Conflict
Fed Nominee Warsh Confirmation Delayed Amidst Financial Scrutiny and Political Hurdles
Tungsten Market Crunch: Rising Military Demand Pushes Prices to Record Highs
Iran Calls for "Thorough Re-evaluation" of Gulf Relations Amidst US-Israeli War
